Cancer letters

Cancer Lett · ISSN (print) 0304-3835 · 4 papers in corpus
other 2020
Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor α antagonism
doi:10.1016/j.canlet.2019.10.019 ·PMID:31629931

Selective estrogen receptor modulators (SERMs) are a class of structurally diverse compounds, which have been extensively used to treat hormone-responsive cancers due to their unique partially agonistic and antagonistic properties toward es…

other 2017
Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells
doi:10.1016/j.canlet.2017.04.040 ·PMID:28483516

The chromatin remodeler AT-Rich Interactive Domain 1A (ARID1A) is frequently mutated in ovarian clear cell carcinoma (OCCC) and endometriosis precursor lesions. Here, we show that knocking down ARID1A in an immortalized endometriosis cell l…

review 2011
Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype
doi:10.1016/j.canlet.2011.06.039 ·PMID:21802200
article 1987
Ovariectomy of adult mice exposed prenatally to diethylstilbestrol
doi:10.1016/0304-3835(87)90001-2 ·PMID:3815324